Lawrence Berkeley National Laboratory is following the shelter-in-place order for California and has reduced onsite staffing levels.

Go to the Lab’s COVID-19 website for more information.

COVID-19 Research at the Lab.

Berkeley Lab launches three new projects to advance sustainable agricultural practices, leveraging the Lab’s strengths in artificial intelligence, sensors, and ecological biology. 
The Dark Energy Spectroscopic Instrument, which will map millions of galaxies in 3D, reaches final milestone toward its startup.
Despite the pandemic, the Daya Bay reactor neutrino experiment in Shenzen, China, has continued to pump data to remote supercomputers for analyses. Berkeley Lab leads U.S. participation in the international physics collaboration.
Laser and biology experts at Lawrence Berkeley National Laboratory (Berkeley Lab) are working together to develop a platform and experiments to study the structure and components of viruses like the one causing COVID-19, and to learn how viruses interact with their surrounding environment. 
The Sanford Underground Research Facility, which is home to the LUX-ZEPLIN dark matter search project, earlier this month began a transition back toward increased operations.
A technology spun from carbon nanotube sensors discovered 20 years ago by Berkeley Lab scientists could one day help health care providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Despite a temporary shutdown of the Dark Energy Spectroscopic Instrument in Arizona – which was in its final stages of testing in preparation to begin mapping millions of galaxies in 3D when the pandemic struck – a variety of project tasks are still moving forward.
A technology spun from carbon nanotube sensors discovered 20 years ago by Berkeley Lab scientists could one day help health care providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Is COVID-19 seasonal like the flu – waning in warm summer months then resurging in the fall and winter? A new project has launched to apply machine-learning methods to health and environmental datasets, combining high-res climate models and seasonal forecasts, to tease out the answer.
An international scientific team has discovered a neutralizing antibody, derived from the blood of a SARS survivor, that inhibits the closely related COVID-19-causing coronavirus. In a paper published this week in Nature, the scientists note that the antibody is already on an accelerated development path toward clinical trials.